In Brief: Micro Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics: To conduct 10-patient clinical investigation of its Embolyx liquid embolic system for the endovascular treatment of arteriovenous malformations in the brain in conjunction with the UCLA School of Medicine after FDA conditionally approved a UCLA-sponsored investigational device exemption earlier in June. The study may begin after approval is obtained from UCLA's institutional review board, the San Clemente, California-based firm says...